A metabolic profile of polyamines in parkinson disease: A promising biomarkerShinji Saiki, Nobutaka Hattori, Koji Kamagata et al.|Annals of Neurology|2019Cited by 123
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Nobutaka Hattori, Shinji Saiki et al.|Neurology|2018Cited by 103